Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158236 · ClinicalTrials.gov registry record · NA
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00158236: Completed NA study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00158236 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158236, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Buprenorphine is a medication used to treat opioid addiction, but individuals who use this drug are at risk of abusing it. A buprenorphine and naloxone combination may reduce the likelihood of buprenorphine addiction. This study will evaluate the potential for abuse of buprenorphine and a buprenorphine and naloxone combination in non-dependent opioid users.
Interventions
- DRUG Hydromorphone
- DRUG Buprenorphine
- DRUG Buprenorphine and Naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 1997-01 |
| Est. Completion | 1998-03 |
| Phase | NA |
What the finished NCT00158236 record still lists
NCT00158236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Hydromorphone is the first listed.
NCT00158236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00158236 about?
NCT00158236 is a clinical study titled "Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users". Buprenorphine is a medication used to treat opioid addiction, but individuals who use this drug are at risk of abusing it. A buprenorphine and naloxone combination may reduce the likelihood of buprenorphine addiction. This study will evaluate the potential for abuse of buprenorphine and a buprenorph...
What is the current status of trial NCT00158236?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 1997-01. Estimated completion is 1998-03.
What interventions are being tested in trial NCT00158236?
The interventions under investigation include: Hydromorphone (DRUG), Buprenorphine (DRUG), Buprenorphine and Naloxone (DRUG).
Who is sponsoring clinical trial NCT00158236?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00158236's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia